Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Industry: Healthcare

Virtual Events by Frictionless Solutions are allowing companies to “Convert vs. Cancel” events during COVID-19

Leave a comment


Frictionless Solutions Logo

“This approach to our business is no different than during 9-11 when we quickly moved our clients to virtual activities (programs). Last week we converted a client’s Brand Launch to a virtual event (Launch). We completed this move in less than 5 business days,” – Michael McCauley, President and CEO


ARLINGTON HEIGHTS, Ill. (PRWEB)

Frictionless has over 50 years of combined healthcare meeting experience, both live & virtual, and is quickly assisting clients to convert in-person events to virtual ones. This quick pivot solves a short-term problem while establishing virtual, remote streaming engagements as long-term initiatives.

“This approach to our business is no different than during 9-11 when we quickly moved our clients to virtual activities (programs). Last week we converted a client’s Brand Launch to a virtual event (Launch). We completed this move in less than 5 business days,” said Michael McCauley, President & CEO of Frictionless Solutions.    

Frictionless has the experience, capabilities, and capacity to make your virtual events a reality. We go beyond providing a virtual platform technology by offering alternatives that include (but are not limited to): virtual speaker programs, conferences/tradeshows, advisory board gatherings, and more. Frictionless goes beyond providing a virtual platform by offering complete, configurable virtual event solutions.

For more information visit: https://frictionlesssolutions.com/

About Frictionless Solutions:

Frictionless Solutions is a leading provider in Healthcare Event Services and Technologies for the Pharma, Medical Device, Diagnostic, Bio-Tec and associated industries.

Address: 415 W. Golf Road, Suite 28, Arlington Heights, IL 60005

Share article on social media or email:

Health

Beauty Is Still a High and Healing Priority in Times of Crisis

Leave a comment


Dr. Shirley Madhere in the news.

“Now, more than ever, it is essential for us all to see and feel beauty within and all around us.”


NEW YORK (PRWEB)

During the global pandemic, consumers are seeking to maintain beauty regimens at home.

Traffic to online virtual consultation tools and telemedicine has increased significantly.

NYC-based plastic surgeon has seen rise in virtual online e-consultation service, Click-Lift.com.

With the majority of the world ordered to shelter in place, citizens are urged to stay home and go out only for essential activities. While purchasing beauty supplies is not critical, many people are seeking to maintain their upkeep virtually or digitally. The rise in online beauty tutorials is a testament to the observation that many people remain invested in their beauty as a form of health and well-being. Moreover, the dominance of communication portals such as Zoom have emphasized the need for some participants to “put their best face forward” as they normally may have done. A Times.com article quotes Dr. Stewart Shankman, chief of psychology at Northwestern Memorial Hospital, as stating “This COVID-19 pandemic is an unprecedented time of uncertainty and uncontrollability. So, people putting makeup on will give them a sense of control given what’s going on outside is uncontrollable.”

Whether to wear makeup or to abandon applying it altogether has its arguments on both sides. However, it isn’t only makeup that beauty encompasses. Many of those who do not wear makeup are reporting upgrading their skincare routines to improve their appearance and confidence. Knowing that healthy skin is a sign of good health, consumers are also choosing to make a positive statement about their state of well-being by ensuring that their skin is flawless and radiant, despite challenging and difficult times.

Where the beauty professional, dermatologist or plastic surgeon, comes into play during these precarious and cautionary times is by continuing to serve their patients through virtual consultations and online visits. In this exceptional context of the worldwide pandemic, NYC-based plastic surgeon and founder of Holistic Plastic Surgery, D. Shirley Madhere, has re-launched the online e-consultation platform, Click-Lift.com, due to popular demand. The site allows users to upload photos and video to describe their beauty and wellness concerns on their own time schedule, no appointment necessary. After a brief questionnaire, Dr. Madhere creates a personalized “Prescription for Healthful Beauty” plan, which may include customized recommendations for skin care as well as nutritional modification and supplement use. There is a nominal fee associated with the site to receive credible and personalized information on holistic beauty, health, and wellness from a medical professional.

“Now, more than ever, it is essential for us all to see and feel beauty within and all around us. I created Click-Lift.com several years ago to better serve my patients while they were traveling. I would not have imagined that the site would continue to serve people well in times of crisis such as these. I am grateful for another opportunity to help others through this fortuitous medium, and I hope that it helps to restore confidence and faith that we shall emerge from this pandemic better and more beautiful—inside and out—together.”

Holistic Plastic Surgery is a philosophy created by Dr. Shirley Madhere to reflect that external appearance is a manifestation of inner health, and as such, healthy skin responds better to the needle and the scalpel. As an additional service, to better assist those people who desired consultations while traveling or abroad, Dr. Madhere created Click-Lift.com as a mobile

e-consultation platform. The site has now been re-launched to serve the increased need of those who seek beauty and wellness advice while away from their standard beauty routines or sources. During the Covid-19 pandemic, Dr. Madhere continues enthusiastically to serve those who invest in this aspect of their wellness not only through this virtual platform but also with her blog on ElementsandGraces.com as well as her podcast, Forever FAB (available on Apple podcasts, Google Play, Spotify, YouTube, and iHeart Radio).

Share article on social media or email:

Health

The American Society for Clinical Pathology Calls on the Federal Government to Develop a National COVID-19 Diagnostic Testing and Support Strategy

Leave a comment


“It is imperative that we save lives by implementing a national diagnostic testing and support strategy,” said ASCP President Gene P. Siegal, MD, PhD, FASCP.


CHICAGO (PRWEB)

The American Society for Clinical Pathology (ASCP) is the first and only national medical organization to call on the federal government to immediately develop and implement a widespread COVID-19 Diagnostic Testing and Support Strategy to help mitigate the Coronavirus Disease (COVID-19) pandemic and deter its spread. The plan will be used by states, healthcare systems, providers, clinical laboratories and others to address patient care needs in this crisis.

“It is imperative that we save lives by implementing a national diagnostic testing and support strategy,” said ASCP President Gene P. Siegal, MD, PhD, FASCP. “The federal government has estimated that hundreds of thousands of lives are at stake. Therefore, in order to flatten the curve, we are calling on the federal government to immediately coordinate resources and work with scientists, the public health community, the private sector and state governments to ensure that we reduce and eliminate unnecessary COVID-19 infections and deaths.”

This strategy must include an expanded laboratory testing infrastructure to empower healthcare systems and clinical laboratories nationwide to provide appropriate diagnostic testing to all patients with or without COVID-19 symptoms, as well as healthcare workers, first responders and other individuals who may have been exposed to the virus.

The goal for widespread, available laboratory testing is to provide patients with a reliable diagnostic test when medically appropriate. In addition, the federal government should also significantly enhance the capabilities of existing surveillance programs to identify outbreaks earlier so that they can be better contained.

This National Diagnostic Laboratory Testing and Support Strategy should, at a minimum, include:

  • The public and private health care sectors are called on to work in concert to rapidly expand appropriate and expeditious diagnostic laboratory testing for the virus responsible for COVID-19, the SARS-CoV-2 virus, to the at-risk population coupled with contact tracing.

  • Molecular testing is the gold standard for diagnosing COVID-19, and it should be the first test of choice for the diagnosis of acute COVID-19 infection. These rapid diagnostics represent the most accurate test methodologies for the detection of the SARS-CoV-2 virus gene sequences during early stage of infection.

  • The federal government should provide funding to diagnostics manufacturers, clinical laboratories and other entities engaged in diagnostics research to support the development of innovative testing devices or components that improve the accuracy and reliability and/or turnaround time of diagnostic or screening tests for COVID-19.

  • COVID-19 serology (IgG/IgM) tests should not be used for the acute diagnosis of COVID-19 as it will miss individuals in the early stage of disease progression, including early stage asymptomatic infection, and cannot reliably identify individuals currently infected with the virus.

  • The integration of accurate and reliable serologic laboratory testing needs to be coordinated with the appropriate experts to ensure that community exposure, prevalence and reliable markers of individual immunity can be accurately and reliably identified.

  • Provide support for the use of convalescent plasma as a therapeutic modality for patient care by providing adequate reimbursement. Reimbursement should also include remuneration for appropriate donors to help defray their medical costs.

  • Congress has guaranteed coverage of testing for COVID-19. This guarantee should be extended to cover diagnostic, screening, and other COVID-19-related testing costs. Moreover, for uninsured patients, the federal and state governments should pay for these tests and subsidize their COVID-19 treatment/hospital costs.

  • The federal government must provide adequate payment for COVID-19 diagnostic and screening tests to ensure clinical laboratories can obtain the financial resources to develop and/or provide these tests.

  • Support for our nation’s public health, community, academic, and private laboratories need to include a supply chain distribution model that will ensure that laboratory testing supply shortages (e.g., swabs, viral transport media, etc.) are addressed immediately.

  • Optimized supply chain management must also assure the safety of our laboratory teams’ (and all healthcare professionals) through the timely availability of personal protective equipment (PPE) to include gloves, masks and face shields, gowns or laboratory coats, and respirators (when appropriate) from point of patient specimen collection through laboratory testing.

  • Financial support should be provided to CLIA-certified anatomic pathology and clinical laboratories during the pandemic and during its immediate aftermath to ensure continued operations to support continuity of patient care. Without such support, the loss of revenue associated with the suspension of elective testing procedures threatens the financial viability of these laboratories and their ability to help expand our nation’s testing capacity.

  • Financial support, in the form of grants and/or student loan forgiveness, should be provided to pathology residents, medical students, and laboratory professionals providing services during the COVID-19 pandemic to defray the costs of academic education and clinical training to ensure that anatomic pathology and clinical laboratories have access to the skilled workforce needed to remain fully operational.

  • Expand the authority of the Secretary of Health and Human Services during a declared public health emergency to waive or provide regulatory flexibility with regard to the federal government’s authority over the development of diagnostics and related supplies/components (FDA per the Federal Food, Drug, and Cosmetic Act and CMS per the Clinical Laboratory Improvement Amendments (CLIA) of 1988) and laboratory testing operations (CMS per CLIA).

  • Healthcare providers, including pathologists, laboratory professionals and other members of the COVID-19 response healthcare team, are putting themselves at extreme risk and are working long hours providing care for patients in need. The federal government and payers should provide hazard pay for individuals involved in diagnosing, treating, and screening patients who may have COVID-19 as well as those professionals who perform forensic pathology and death investigations. These benefits should be made available to the beneficiaries of healthcare professionals who succumb to COVID-19.

  • The federal government should provide the Secretary of Health and Human Services with the authority to compel hospitals, public and private laboratories and other providers to report information, such as laboratory test performance data and patient-specific symptomatic information, pertinent to ensure robust public health surveillance capabilities.

By implementing a national testing strategy, we can slow the spread of COVID-19. In doing so, we not only help patients, we also alleviate the mounting pressure on healthcare systems across the country. For more information, visit http://www.ascp.org/COVID-19.

About ASCP

Founded in 1922 in Chicago, ASCP is the world’s largest professional membership organization for pathologists and laboratory professionals. ASCP provides excellence in education, certification, and advocacy on behalf of patients, anatomic and clinical pathologists, and medical laboratory professionals. To learn more, visit http://www.ascp.org. Follow us on Twitter at http://www.twitter.com/ascp_chicago and connect with us on Facebook at http://www.facebook.com/ASCP.Chicago.

Share article on social media or email:



Health

Designs for Health Announces the first Company-wide Coronavirus Antibody Testing

Leave a comment


News Image

The test is one of the first indicators that will help organizations, companies, medical professionals, etc., to begin the process of assessing how to roll out a back to work strategy.


PALM COAST, Fla. (PRWEB)

Designs for Health, Inc. (DFH) – a leading practitioner-channel dietary supplement and nutraceutical company, announces the first company-wide coronavirus antibody testing will be taking place for their employees and contractors on Thursday, April 16th. The FDA-approved blood serum test is designed to detect antibodies to the virus that causes COVID-19 (the virus is named SARS-CoV-2.) Antibodies are produced by your immune system as part of its response to fighting foreign invaders like viruses. Test results may indicate one of three primary outcomes:


  • Active infection

  • Past infection and some level of immunity

  • No exposure and no immunity

The level of immunity and the length of time it lasts are not known, but researchers are actively working to understand this. According to Dr. David Brady, Chief Medical Officer, for both Designs for Health, Inc., and Diagnostic Solutions Laboratory, “The test is one of the first indicators that will help organizations, companies, medical professionals, etc., to begin the process of assessing how to roll out a back to work strategy. Currently there are no guidelines as to how companies and people should prepare for this, though we believe tests such as this will form part of this guidance.”

Diagnostic Solutions Laboratory (DSL) has developed three critical tests for COVID-19 and SARS-CoV-2: an oral and nasopharyngeal swab diagnostic test for COVID-19, and a stool analysis and blood serum test for SARS-CoV-2. The blood serum test provides information about whether an individual’s immune system has responded in some way to an exposure to SARS-CoV-2. The results will help understand whether an individual has been exposed to the virus, and if so, whether some level of immunity is present. This test can be used for screening of both people with symptoms and people without symptoms, which is extremely important as recent studies suggest a high percentage of people who carry the virus show no clinical symptoms. As a blood draw is necessary, these tests will only be conducted under the order of an appropriately licensed healthcare provider and administered by licensed phlebotomists, and the results are strictly governed by HIPAA regulations. “This is a much more accurate test than the bloodspot test that is also currently being used on individuals who are asymptomatic. Without doing a blood draw and getting enough serum, you cannot accurately find people who have been exposed in the past, and, more importantly, have some level of immunity,” commented Tony Hoffman, President and CEO, Diagnostic Solutions Laboratory.

As an essential business, DFH, has been working to maintain adequate supplies of much needed dietary supplements and nutraceuticals to meet physician and consumer demand. Jonathan Lizotte, Founder and Chairman of Designs for Health, Inc., felt that taking this first step towards trying to normalize the process of returning to work would help give employees some peace of mind. “We are living in unchartered times and whatever we can do to help people through this terrible crisis we will,” said Lizotte. “All the tests will be performed by Diagnostic Solutions Laboratory, and the results will be sent directly to each individual along with general information about the range of possible results. DFH will have no access to the employees’ individual results, which are their personal health information. We have instructed people whose antibody test shows they may be fighting an active infection to self-quarantine and contact their healthcare provider right away. If the results indicate a past infection and current immunity, they may be a good candidate to donate plasma. We will provide information about where employees can donate plasma in their local areas when this information becomes available. At the end of the day, the health of everyone in our company is a top priority for us.”

According to experts, it will be important to understand how much the SARS-CoV-2 virus has spread throughout society, and while the logistics of testing everybody will not be feasible, gathering data from a statistically relevant number of the population will be critical in understanding long term health implications and treatments.

As companies, states and governments look to both health and economic recovery, it will take a concerted effort from both the public and the private sector to navigate short- and long-term strategies that are both equitable and sustainable.

Testing for DFH employees and contractors will be taking place on Thursday April 16th in the following locations, maintaining the appropriate social distancing, hand hygiene, and enhanced sanitation guidelines:

FLORIDA:        14 Commerce Blvd, Palm Coast, FL 32164

CONNECTICUT:     980 South Street. Suffield, CT 06078.

Testing will be made available to employees and contractors at other US and international DFH locations as soon as phlebotomists become available and regulations allow.

About Designs for Health:

Family-owned Designs for Health, Inc. offers high-quality dietary supplements and functional foods to healthcare professionals and their patients. Guided by its founding philosophy of “Science First,” the company holds an unwavering commitment to creating research-driven formulations with meaningful quantities of therapeutic ingredients that maximize the potential for successful health outcomes. For over 30 years, Designs for Health has been many healthcare professionals’ trusted source for not only product innovation, but also leadership in clinical education and practice development solutions.

To learn more, visit https://www.designsforhealth.com or call 800.847.8302.

About Diagnostic Solutions Laboratory:

Diagnostic Solutions Laboratory is the leader in DNA-based functional medicine testing. In addition to the new COVID-19 SARS-CoV-2 testing options, DSL offers the GI-MAP stool test, which accurately and quantitatively detects parasites, bacteria, fungi, and other opportunistic organisms to provide insight into gut and immune health. DSL also offers the GenomicInsight™ Genomic Health Profile, which uses the advanced artificial intelligence powered by Opus 23 Explorer® to provide unique insight into patient genomics.

Learn more about Diagnostic Solutions Laboratory and its testing at https://diagnosticsolutionslab.com or call 877-485-5336.

For media inquiries, or to arrange interviews, please contact Giselle Chollett at giselle@adinnyc.com, or 917.386.7116.

Share article on social media or email:

Health

Student Organization Launches ‘Worldwide Day of Gratitude’ to Honor COVID-19 Heroes

Leave a comment


News Image

“To show our gratitude, teachers, students, and people of all ages can use the power of music and the arts to unite to honor these amazing heroes.” –Andrew E. Morrison, co-founder of YOUnison.


WARREN, N.J. (PRWEB)

First responders and healthcare workers on the front lines of the COVID-19 pandemic will be honored on April 30 as part of “Worldwide Day of Gratitude,” a global coming together through the arts organized by the student-run organization, YOUnison.

Music has long served as a unifying force during challenging times. For Worldwide Day of Gratitude, teachers and students of all ages, as well as the general public, are invited to learn and share the iconic Bill Withers song, “Lean on Me,” which has emerged as a rallying cry for the COVID-19 pandemic.

Starting April 14, sheet music authorized by Hal Leonard Corporation, as well as sample lesson plans and thought starters for participation are available at https://www.younison.org/leanonus.

Participants are encouraged to download the materials, then record and share their unique versions on YouTube and post on social media channels using the hashtags #LeanOnUs and #DayOfGratitude.

“The effort put forth by the first responders and healthcare workers has been incredibly inspiring to so many around the world,” said Andrew E. Morrison, co-founder of YOUnison, a student-centered community empowering YOU to achieve musical excellence based around self-directed learning, creativity and collaboration. “To show our gratitude, teachers, students, and people of all ages can use the power of music and the arts to unite to honor these amazing heroes.”

The Worldwide Day of Gratitude has attracted the attention and collaboration from the leading organizations in music and education, including Arts Ed NJ, CMA Foundation, D’Addario Foundation, Drum Corp International, Grammy Music Education Coalition, Hal Leonard Corporation, John Lennon Educational Tour Bus, Little Kids Rock, Music for All, Mr. Holland’s Opus Foundation, NAMM Foundation, Noteflight, Rock and Roll Forever Foundation, Save The Music Foundation, Teach Rock, Yamaha and YOUnison.

To download sheet music and sample lessons, and to learn more about YOUnison, please visit http://www.younison.org/leanonus

About YOUnison

A student-centered community empowering YOU to achieve musical excellence based around self-directed learning, creativity, and collaboration. YOUnison’s mission is to redefine lifelong individual development through music, leadership and social-emotional learning.

Learn more at http://www.younison.org or contact the team at info@younison.org.

Share article on social media or email:

Health

The Case Management Society of America Announces Newly Elected Members of the 2020-2023 Board of Directors

Leave a comment


News Image

“Our new board members will provide fresh perspectives and assist us in developing innovative solutions during these uncertain times.”


Little Rock, AR (PRWEB)

CMSA’s membership has elected a treasurer and two national directors to the CMSA National Board. In addition to these three new positions, the current President-Elect Melanie Ann Prince, BSN, MSN, RN-BC, CCM will begin her term as President for 2020-2022. These leaders will be sworn in on July 1, 2020.

“More than ever, CMSA requires a strong, selfless foundation of leadership as we continue to navigate the fast pace of change in all aspects of healthcare. The newly elected board members are longtime members and contributors to CMSA national and their local chapters and accomplished professional case managers. Our incoming president, Melanie Prince, and I are so pleased to welcome them to our national board this summer,” stated Kathleen Fraser, MSN, MHA, RN-BC, CCM, CRRN, FAAN, CMSA national executive director.

CMSA president Jose Alejandro, PhD, RN, FAAN remarked, “It is a pleasure to welcome our new board members. I look forward to working with them to advance our mission and strategic vision. Our new board members will provide fresh perspectives and assist us in developing innovative solutions during these uncertain times.”

The following three members will be installed to their new positions on the CMSA Board of Directors:

TREASURER

Patricia Noonan, RN, MBA, CCM

2020-2023

DIRECTORS

Mark Evans, MA, CCM, CRC, CBIS

2020-2023

Jenny Quigley-Stickney, MSN, RN, BSN, MHA, MA, CCM, ACM-RN, CPHM

2020-2023

About the Case Management Society of America (CMSA)

Established in 1990, the Case Management Society of America is the leading non-profit association dedicated to the support and development of the profession of case management. CMSA serves more than 30,000 members, subscribers and participants, and 85 chapters worldwide, through educational forums, networking opportunities, legislative advocacy and established standards to advance the profession. For more information, visit http://www.cmsa.org or follow CMSA on Twitter @CMSANational.

Share article on social media or email:

Health

Boober Leads Pregnant And New Parents Through COVID-19

Leave a comment


Jada Shapiro boober founder

Helping expectant parents and new families find expert maternal care is at our core. We are committed to always finding the best way to deliver that critical help, whatever the circumstances.


BROOKLYN, N.Y. (PRWEB)

The COVID-19 pandemic may have transformed nearly every aspect of our society, but babies continue to be born. Over 2 million babies will be born in the US in the next six months. Pregnant families and new parents are isolated, worried about contagion, and facing birth and postpartum without helpful visitors and with fewer resources than before.

Boober, the beloved platform that connects expectant and new parents to lactation support, birth doulas, postpartum support, and licensed mental health therapists is once again answering parents’ desperate calls for help. The startup has quickly shifted to provide virtual assistance to ensure that expecting, birthing, and new parents continue to receive the critical help they need to thrive in the face of this pandemic.

“Helping expectant parents and new families find expert maternal care is at our core,” says boober founder Jada Shapiro. “We are committed to always finding the best way to deliver that critical help, whatever the circumstances.”

BOOBER’S VIRTUAL MATERNAL CARE PROVIDERS HELP NEW PARENTS THRIVE DURING THE ISOLATION OF COVID-19.

While boober is passionate about in-person care, it is committed to making sure parents can always get the critical support they need, even as the mandates for social distancing become the norm and hospitals are shutting their doors on labor support—and sometimes partners. All care providers on the boober platform now use a secure video telehealth platform to provide virtual care, including lactation support, virtual doula services, postpartum assistance, and mental health support. One-on-one phone sessions are also available. “My provider’s very clear explanations made our remote consultation equally as effective as an in-home visit,” said one happy mother, following a recent virtual lactation visit, “Would highly recommend!”

BOOBER IS COMMITTED TO PROVIDING COVID-19 RESOURCES AND INFORMATION IN CHANGING TIMES.

The company has been very active in helping families get resources, information, and answers in real-time. Boober maintains a COVID-19 resource page and runs free webinars with OBGYNs, pediatricians, and board-certified lactation consultants, which have attracted thousands of expectant and new parents.

WITH ANXIETY SKYROCKETING, BOOBER LAUNCHES A NEW MENTAL HEALTH SERVICE AHEAD OF SCHEDULE.

In this climate, new parents are facing unprecedented levels of anxiety and stress due to isolation, fear of birthing in hospitals overrun with coronavirus patients, a lack of clear answers, and economic challenges. This need has prompted boober to shift its attention toward providing mental health services. Boober is now matching new parents to virtual licensed mental health therapists who specialize in supporting parents during pregnancy, birth, postpartum and early parenting.

BOOBER PERFECTS THE VIRTUAL DOULA IN RESPONSE TO THE LIMITATION ON SUPPORT PEOPLE IN HOSPITALS.

Pregnant people are turning to virtual doulas to prepare and get them through birth. Virtual doulas on the boober platform can provide continual video support on a laptop or phone, giving vital emotional and informational assistance. They can share visual guidance on pain relief tools and techniques, help reduce stress, and provide comfort. (Doulas can also be available by phone or text 24-7, should continual video support not work or be preferable.)

BOOBER VIRTUAL VISITS ARE AVAILABLE NATIONWIDE: MORE HELP FOR MORE PEOPLE.

In the past 2 years, boober has helped over 3,500 families in the NYC metro area get in-person support. With the addition of virtual care, boober is now assisting families across the country. With parental requests coming in from Michigan, Los Angeles, Chicago, Hawaii and more, boober has also seen a surge in care providers joining boober from all over the country.

While the company is committed to re-introducing in-person care as soon as safety allows, boober’s greater reach through virtual care allows the company to continue to deliver on its mission of transforming healthcare experiences and outcomes for families.

Share article on social media or email:

Industry: Healthcare

Synergy HomeCare Announces Executive Team Expansion to Support Growth Plan

Leave a comment


News Image

“It has been incredibly rewarding to see our best-in-class system evolve and attract so many caring entrepreneurs into our growing network,” Tourian said.


GILBERT, Ariz. (PRWEB)

SYNERGY HomeCare, a leading in-home care franchisor, today announced that company founder Peter Tourian has been promoted to Executive Chairman. The company also announced that franchising veteran Charlie Young has been named Chief Executive Officer.

Tourian founded the company in 1999 and launched its franchise system in 2005. SYNERGY HomeCare has grown to become one of the nation’s top performing in-home care providers located in 338 markets, a 194% increase since 2010. Franchise Times recently reported that SYNERGY HomeCare was the third fastest growing franchise in the home healthcare industry with 13.8% year-over-year sales.

“It has been incredibly rewarding to see our best-in-class system evolve and attract so many caring entrepreneurs into our growing network,” Tourian said. “We are extremely well positioned for expansion. Charlie Young brings to our organization an incredible background in franchise leadership to help us go after these opportunities for growth.”

Young spent the last 18 years in leadership at such noted franchisors as Cendant and Realogy Holdings Corp., where he served the last four years as President and CEO of Coldwell Banker Real Estate. He oversaw a system of more than 700 franchisees and 3,000-plus offices in 44 countries. Prior to being named to the top position at Coldwell Banker in 2016, Young spent seven years as President and CEO of ERA Franchise Systems.

“Home care is a noble profession, where the opportunity to grow and provide outstanding care and service go hand-in-hand. SYNERGY is a leading brand that is poised for explosive growth and I’m looking forward to enhancing our presence, working with Peter and the incredible team of franchisees,” said Young.

About SYNERGY HomeCare

With over 20 years of brand equity, SYNERGY HomeCare is one of the largest franchisors of in-home care services with 338 franchise markets nationwide. The company provides a range of services including non-medical personal care, companion care, and specialized care for individuals who are physically or developmentally disabled, living with chronic health conditions or recovering from illness or surgery. SYNERGY HomeCare helps their clients achieve the highest quality of life and independence attainable.

Share article on social media or email:

Health

CPAP Store USA Prepared for Increased CPAP, BiPAP and Oxygen Concentrators Demand After FDA Authorizes CPAP Machines And More As Emergency Ventilator Alternatives

Leave a comment



LOS ANGELES (PRWEB)

The most popular multiple-location retail respiratory CPAP Stores and it’s leading online store serving millions of people with obstructive sleep apnea is committed to continue to support their customers and community, and stands ready to assist in the domestic response to COVID-19 (coronavirus). For patients battling this virus and for the caregivers, respiratory therapists, and medical professionals working tirelessly to prepare and respond, CPAP Store USA’s team is committed to support.

During the ‘Shelter in Place’ order issued on March 20, 2020, CPAP Store USA, classified as an essential business, will remain open and continue to operate its retail stores seven days a week with extended hours at selected retails locations nationwide to provide respiratory support during outbreaks of serious infectious diseases – specifically, the supply for CPAP, BiPAP and Oxygen Concentrators.

The warehouse and the online store, CPAPStoreUSA.com, will also remain open and continue to process and ship out products to their customers with free priority mail shipping nationwide. As of now, the wearhouse continues to maintain a complete inventory of products, including CPAPs, BiPAPs & BiLevels, Oxygen Concentrators and all other necessary supplies.

“At CPAP Store USA, we recognize that our CPAPers are relying on our services and products especially now, with the progression of the Novel Coronavirus (Covid-19) pandemic. CPAP Store USA has made it a priority to not only keep people supplied with the equipment they need, but also ensure they are up-to-date on the recent information regarding CPAPs, BiPAP, Oxygen Concentrators, Nebulizers and COVID-19.” – states Marina BerBeryan, CPAP Store USA’s Brand Ambassador. “For that reason, CPAP Store USA has ordered and received extra inventory to service it’s customers.”

FDA recommends airway pressure devices such as CPAP machines used to treat sleep apnea and portable oxygen generators for chronic obstructive pulmonary disease as an emergency possible treatment for milder cases of COVID-19 positive Ventilator Alternatives.

On March 22, 2020 FDA made a statement on COVID-19 treatment options, the FDA is recommending

“the alternatives ( to ventilators) that should be considered such as devices for treating sleep apnea, continuous positive airway pressure (CPAP), devices..*

Additionally, the FDA provides modifications to indications, claims or functionality that would not create an undue risk:

Use of devices intended for sleep apnea to treat patients with respiratory insufficiency when appropriate design mitigations are in place to minimize aerosolization; and

Use of oxygen concentrators for primary supply when medically necessary and clinically appropriate.

Patients with COVID-19 may develop respiratory illness, distress, and insufficiency and may require respiratory devices to support their treatment. However, with the number of confirmed cases in the U.S. increasing daily, there is growing concern that the supply of respiratory devices to treat patients with COVID-19 is insufficient to meet demand.

For additional information on CPAP, BiPAP and Oxygen Concentrator products visit http://www.CPAPStoreUSA.com

CPAP Store USA Locations:

CPAP STORE USA

3325 W Desert Inn Road, Suite 201

Las Vegas, Nevada 89102

https://www.CPAPStoreUSA.com

(888)512-7278

CPAP STORE LAS VEGAS

3325 W Desert Inn Road, Suite 301

Las Vegas, Nevada 89102.

https://www.CPAPStoreLasVegas.com

(800) 479-1308

CPAP STORE LOS ANGELES

1551 N. La Brea Ave, Unit A,

Los Angeles, California, 90028

https://www.CPAPStoreLosAngeles.com

(800) 479-1308

CPAP STORE AGOURA HILLS

5160 Kanan Road

Agoura Hills, California, 91301

https://www.CPAPStoreAgouraHills.com

(888)223-1605

CPAP STORE DALLAS

3920 Rosemeade, Suite 150

Dallas, Texas 75287

https://www.CPAPStoreDallas.com

(800) 598-0524

CPAP Store Dallas Fort Worth

5205 Davis Blvd, Ste G

North Richland Hills, Texas 76180

https://www.CPAPStoreDFW.com

(800)940-0327

Follow CPAP Store USA at

Facebook: @CPAPstoreUSA

Twitter: @CPAPstoreUSA

Instagram: @CPAPstoreUSA

LinkedIn: @CPAPstoreUSA

Google+: @CPAPstoreUSA

Yelp: @CPAPstoreUSA

Hollywood Times PR

Olga Love

HollywoodTimePR(at)aol(dot)com

Article Sources*

Source 1* https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-continues-facilitate-access-crucial-medical-products-including

Source 2* https://www.fda.gov/media/136318/download

Share article on social media or email:

Industry: Healthcare

Systech Launches Brand Protection Innovation Series to Educate Global Brands and Supply Chain Participants

Leave a comment


As we navigate this new reality of social distancing, it behooves us to discover new ways to stay informed and connect with our industry peers.


PRINCETON, N.J. (PRWEB)

Systech, the leader in digital brand protection, today announced it is providing a complimentary online weekly series of conversational webinars. These sessions span global supply chain issues including brand protection, with a focus on how to stay one step ahead of increasingly sophisticated counterfeiters and gray market criminals. The Brand Protection Innovation Series begins Wednesday, April 15, 2020.

“As we navigate this new reality of social distancing both personally and professionally, it behooves us to discover new ways to stay informed and connect with our industry peers. This is what inspired Systech to join forces with customers and partners – experts across industries – to launch the series,” says Jefferson Barr, vice president of marketing at Systech.

Anyone from the pharmaceutical, cosmetics and beauty, wine and spirits, food and beverage, and other industries is invited to subscribe to the 20-minute live conversations. Industry experts and academia will converse on how to tackle and solve difficult global supply chain challenges. Topics include:


  • Product counterfeiting and diversion

  • Supply chain track and trace

  • Intelligent packaging solutions

  • Consumer mobile engagement

  • Innovative technologies that increase supply chain visibility

  • Understanding how to measure brand protection ROI

Listeners are encouraged to bring insights and ideas to the conversation. This is a weekly series running every Wednesday at 11am ET. The first two episodes are April 15 and April 20.

April 15 – Susanne Somerville, CEO of Chronicled

Saleable returns and Blockchain for the pharma supply chain.

April 22 – David Yingling, Brand Protection and Product Security, Johnson & Johnson

Get a look inside how Johnson & Johnson disrupts the illicit trader’s ability to mimic products and how they’re making it easier to identify what is genuine vs. suspect.

Register here to tune in to the complimentary Brand Protection Innovation Series. All conversations will be recorded and available later as on-demand episodes.

About Systech:

Systech International, a Princeton, New Jersey-based company, has developed an innovative software suite of authentication and traceability solutions to combat counterfeiting, prevent diversion and meet regulatory compliance. Built on decades of experience as the leader in pharmaceutical serialization, Systech is revolutionizing brand protection with its comprehensive suite that delivers the real-time insight, actionable product data, digital connectivity and consumer engagement functionality needed to fight supply chain threats. Global brands across industries rely on Systech to keep their products authentic, safe and connected as they move through the supply chain.

Media Contact:

Jefferson Barr, VP Marketing

+1 609-235-8446

Jefferson.barr@systechone.com

Share article on social media or email: